These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34770799)

  • 1. The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin.
    Lin YK; Yang SC; Hsu CY; Sung JT; Fang JY
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Biofilm Interactions: The Role of the EPS Matrix.
    Fulaz S; Vitale S; Quinn L; Casey E
    Trends Microbiol; 2019 Nov; 27(11):915-926. PubMed ID: 31420126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-biofilm activity of zinc oxide and hydroxyapatite nanoparticles as dental implant coating materials.
    Abdulkareem EH; Memarzadeh K; Allaker RP; Huang J; Pratten J; Spratt D
    J Dent; 2015 Dec; 43(12):1462-9. PubMed ID: 26497232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence.
    Horev B; Klein MI; Hwang G; Li Y; Kim D; Koo H; Benoit DS
    ACS Nano; 2015 Mar; 9(3):2390-404. PubMed ID: 25661192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm.
    Hernandez-Delgadillo R; Velasco-Arias D; Diaz D; Arevalo-Niño K; Garza-Enriquez M; De la Garza-Ramos MA; Cabral-Romero C
    Int J Nanomedicine; 2012; 7():2109-13. PubMed ID: 22619547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Polymeric Matrix Composition of
    Abriat C; Gazil O; Heuzey MC; Daigle F; Virgilio N
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35356-35364. PubMed ID: 34286588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines for antimicrobial interventions.
    Cavalieri F; Tortora M; Stringaro A; Colone M; Baldassarri L
    J Hosp Infect; 2014 Dec; 88(4):183-90. PubMed ID: 25447199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of probiotics in skin: adhesion, antimicrobial and antibiofilm in vitro assays.
    Lopes EG; Moreira DA; Gullón P; Gullón B; Cardelle-Cobas A; Tavaria FK
    J Appl Microbiol; 2017 Feb; 122(2):450-461. PubMed ID: 27862685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.
    Dos Santos Ramos MA; Da Silva PB; Spósito L; De Toledo LG; Bonifácio BV; Rodero CF; Dos Santos KC; Chorilli M; Bauab TM
    Int J Nanomedicine; 2018; 13():1179-1213. PubMed ID: 29520143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial biofilms associated skin disorders: Pathogenesis, advanced pharmacotherapy and nanotechnology-based drug delivery systems as a treatment approach.
    Vyas T; Rapalli VK; Chellappan DK; Dua K; Dubey SK; Singhvi G
    Life Sci; 2021 Dec; 287():120148. PubMed ID: 34785190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Nanoparticles in the Inhibition of Multidrug-Resistant Bacteria and Biofilms.
    AlMatar M; Makky EA; Var I; Koksal F
    Curr Drug Deliv; 2018; 15(4):470-484. PubMed ID: 29219055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Antibiofilm Nanocomposites: Ag/Cu Bimetallic Nanoparticles Synthesized on the Surface of Graphene Oxide Nanosheets.
    Jang J; Lee JM; Oh SB; Choi Y; Jung HS; Choi J
    ACS Appl Mater Interfaces; 2020 Aug; 12(32):35826-35834. PubMed ID: 32667802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for antimicrobial drug delivery to biofilm.
    Martin C; Low WL; Gupta A; Amin MC; Radecka I; Britland ST; Raj P; Kenward KM
    Curr Pharm Des; 2015; 21(1):43-66. PubMed ID: 25189862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for Signaling in Biodiagnosis and Treatment of Infectious Diseases.
    Colino CI; Millán CG; Lanao JM
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives.
    Panthi VK; Fairfull-Smith KE; Islam N
    Int J Pharm; 2024 Apr; 655():124046. PubMed ID: 38554739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green synthesis of silver nanoparticles using Carum copticum: Assessment of its quorum sensing and biofilm inhibitory potential against gram negative bacterial pathogens.
    Qais FA; Shafiq A; Ahmad I; Husain FM; Khan RA; Hassan I
    Microb Pathog; 2020 Jul; 144():104172. PubMed ID: 32224208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiofilm Action of ZnO, SnO
    Khan F; Lee JW; Pham DNT; Khan MM; Park SK; Shin IS; Kim YM
    Recent Pat Nanotechnol; 2020; 14(3):239-249. PubMed ID: 32167434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
    Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing antibiofilm activity with functional chitosan nanoparticles targeting biofilm cells and biofilm matrix.
    Tan Y; Ma S; Leonhard M; Moser D; Haselmann GM; Wang J; Eder D; Schneider-Stickler B
    Carbohydr Polym; 2018 Nov; 200():35-42. PubMed ID: 30177175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.